Ketamine-Based Treatment of MDD: A Biologist’s Perspective

Journal Title: Journal of Depression and Therapy - Year 2017, Vol 1, Issue 3

Abstract

Ketamine’s potential as a fast-acting reagent to treat MDD, especially treatment-resistant depression has caught much attention recently. Although much has been learned about the biological mechanisms underlying ketamine’s effect, there are a few critical issues remained to be resolved. This mini review will briefly discuss several controversial issues that warrant further studies, regarding the molecular, physiological, psychopharmacological, and behavioral effects of ketamine. Understand how ketamine works as an anti-depressant will open the door to better understanding of MDD and its treatment.

Authors and Affiliations

Shupeng Li, Yingli Zhang, Qiang Zhou

Keywords

Related Articles

Psychosocial Factors and Comorbidity Associated with Recovery in Bipolar Disorder

Bipolar disorder (BD) is a chronic psychiatric illness impacting patient functioning and quality of life. Medication produces improvement in many patients and remission in some, but there is minimal understanding about...

Basal Serum Cortisol Levels, Depression and Medial Temporal Lobe Atrophy in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

Objectives: Changes in serum cortisol levels have been reported in Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI). Atrophy of Medial Temporal Lobes (MTLs) is common in both conditions. Glucocorticoids are k...

Differentiating Depression from Apathy in Chronic Kidney Disease: A Prospective Study

Background. Emotional deterioration is frequently found in patients with chronic kidney disease, but some patients are affected by depressed mood without fulfilling the criteria of a depressive disorder. Those patients m...

A Randomized Controlled Biofeedback Intervention Study On Heart Rate Variability In Unemployed Subjects

Background: Unemployment is a chronic stressor which is associated with higher levels of impaired physical and mental wellbeing, e.g. reduced heart rate variability (HRV) and decline in self-esteem and self-efficacy. Th...

A Specific Case of Non-Specificity: Longitudinal Effects of Dysfunctional Attitudes on Depressive, Eating Disorder and Aggressive Symptoms in Children and Adolescents

An important step in the validation of disorder-specific etiological models is the examination of the predictive specificity of proposed vulnerability factors. It may advance the understanding of the emergence of comorbi...

Download PDF file
  • EP ID EP262527
  • DOI 10.14302/issn.2476-1710.jdt-17-1673
  • Views 130
  • Downloads 0

How To Cite

Shupeng Li, Yingli Zhang, Qiang Zhou (2017). Ketamine-Based Treatment of MDD: A Biologist’s Perspective. Journal of Depression and Therapy, 1(3), 29-34. https://europub.co.uk/articles/-A-262527